Sometimes, it’s the pressing election issues that no one is talking about that matter most. Especially when the omission is ...

A lack of suitable candidates has forced HSBC Holdings (NYSE:HSBC) (OTCPK:HBCYF) to renew its search for the company’s next ...

Goldman Sachs posted strong Q2 results, raised dividends 33%, and sees AI-driven growth ahead, despite valuation risks after ...

Tesla (NASDAQ:TSLA) stock has been trending sideways lately, as investors weigh the company’s longer-term delivery prospects ...

As data centers expand to meet the rising demands of AI, can renewable energy infrastructure scale fast enough to support ...

Executives at five of the largest US banks shared their plans for stablecoin as regulations passed by Congress head to the ...

Not all of the old Garden is gone -- evidently, much of the Celtics' original home arena has found its way into the floor of ...

A Goldman Sachs basket of unprofitable technology stocks hit its highest level since April 2022 following a 60% rally off the April 8 year-to-date low. Speculative "story" stocks have seen strong ...

The major stock indexes are wobbling shortly after the open--but the Dow is the biggest laggard. It's down by 177 points, or 0.4% this morning. The blame lies with some of the highest-weighted ...

Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

Lucid's share price is on the move. Here's what its partnership with Uber and Nuro means for the future of transportation.

Alkermes plc (NASDAQ:ALKS) is one of the high-margin pharma stocks to buy now. Goldman Sachs has initiated coverage of ...